Comment: Blinatumomab for acute lymphocytic leukaemia

Visit http://www.ecancer.org for more.

Dr Bollard (George Washington University, Washington, USA) talks to ecancertv about key abstracts showcased at ASH 2014. Here, she addresses Dr Nicola Gökbuget's study on the use of blinatumomab for the treatment of acute lymphocytic leukaemia.

Read the news story here.

Dr Bollard is also a member of the Division of the Blood and Marrow Transplantation and senior scientist at the Children National Health System's Center for Cancer and Immunology Research at Children’s Research Institute. She is the Principal Investigator and the Sheikh Zayed Institute for Pediatric Surgical Innovation.